The subtalar joint — the articulation between the talus and calcaneus — is the primary joint governing foot inversion and eversion. Subtalar joint injections serve both diagnostic and therapeutic purposes, providing targeted corticosteroid delivery for subtalar arthritis, synovitis, and post-traumatic inflammation that fails to respond to oral anti-inflammatory therapy.

Anatomy and Clinical Significance

The subtalar joint complex consists of three facets: the posterior, middle, and anterior facets. The posterior facet is the largest and most clinically relevant, accountable for the majority of subtalar motion. The sinus tarsi — a fatty recess lateral to the posterior subtalar facet — is the standard injection access point and the site of sinus tarsi syndrome, a common source of lateral hindfoot pain following inversion sprains.

Indications for Subtalar Injection

Primary indications include subtalar osteoarthritis (isolated or post-calcaneal fracture), sinus tarsi syndrome, subtalar synovitis from inflammatory arthropathy (rheumatoid, psoriatic, gout), and diagnostic injection when subtalar versus ankle pathology is unclear. Subtalar injections may also precede or follow subtalar fusion decisions to confirm the joint as the pain generator and assess functional significance of motion loss.

Injection Technique

The standard approach targets the sinus tarsi via a lateral approach with the patient supine or in lateral decubitus position with slight plantar flexion and inversion of the foot. The needle is directed anteriorly and slightly medially into the sinus tarsi. Fluoroscopic or ultrasound guidance significantly improves accuracy — blind injection accuracy is reported at only 50–65% versus 90–95% with image guidance. Dr. Biernacki performs subtalar injections under diagnostic ultrasound guidance for precise delivery.

Corticosteroid vs. Viscosupplementation

Corticosteroid injections (typically triamcinolone acetonide 20–40mg or methylprednisolone acetate 40mg with local anesthetic) provide rapid symptom relief lasting weeks to several months. Viscosupplementation with hyaluronic acid derivatives has shown benefit in small series for subtalar arthritis, though evidence is less robust than for the tibiotalar or knee joint. PRP injection is an emerging option for recalcitrant subtalar synovitis without significant structural arthritis.

Expected Outcomes and Frequency

Most patients experience meaningful pain relief within 3–5 days of corticosteroid injection, with duration of relief correlating with underlying structural severity. Injections are typically limited to 3–4 per year per joint to minimize risk of cartilage degradation and periarticular tissue atrophy. A positive diagnostic response (50%+ pain reduction) to subtalar injection confirms the joint as the primary pain source and is valuable information when considering subtalar fusion.

Subtalar Joint Injections at Balance Foot & Ankle

Dr. Biernacki at Balance Foot & Ankle performs ultrasound-guided subtalar joint injections with on-site diagnostic ultrasound equipment — providing accurate delivery without radiation exposure. Injections are offered as part of a comprehensive hindfoot pain evaluation including weight-bearing X-ray and clinical biomechanical assessment. Call (810) 206-1402 for a same-week appointment.

Dr. Tom Biernacki, DPM

Dr. Tom Biernacki, DPM is a double board-certified podiatrist and foot & ankle surgeon at Balance Foot & Ankle Specialists in Southeast Michigan. With over a decade of clinical experience, he specializes in heel pain, bunions, diabetic foot care, sports injuries, and minimally invasive surgery. Dr. Biernacki is a member of the APMA and ACFAS, and his patient education content on MichiganFootDoctors.com and YouTube has reached over one million views.